Table 3.
Estimates for the mean % change in the within-session 1st and 2nd standardized gray matter density measurements {i.e., [(2nd – 1st)/1st]*100%} for Alzheimer's disease patients.
| Alzheimer's Disease Patients | ||||||
|---|---|---|---|---|---|---|
| Brain region | Mean % change | Lower 95% CI | Upper 95% CI | P-value | B&H threshold | Reject |
| Auditory Te1 1 | −1.15 | −1.92 | −0.38 | 0.004 | 0.00192 | No |
| TE1.0 | −1.01 | −1.74 | −0.27 | 0.008 | 0.002 | No |
| TE1.2 | −0.95 | −1.84 | −0.05 | 0.038 | 0.00263 | No |
| CA2 | −0.81 | −1.35 | −0.27 | 0.004 | 0.00185 | No |
| BA45 | −0.76 | −1.36 | −0.16 | 0.014 | 0.00208 | No |
| SUBC | −0.68 | −1.33 | −0.03 | 0.042 | 0.00278 | No |
| DG | −0.67 | −1.29 | −0.05 | 0.035 | 0.00238 | No |
| TE3.0 | −0.62 | −1.2 | −0.05 | 0.035 | 0.00227 | No |
| V1 | −0.56 | −1.19 | 0.06 | 0.077 | 0.00294 | No |
| BA44 | −0.56 | −1.28 | 0.16 | 0.124 | 0.00333 | No |
| LB | −0.55 | −1.7 | 0.6 | 0.339 | 0.00455 | No |
| V1 | −0.52 | −1.01 | −0.03 | 0.037 | 0.0025 | No |
| CA1 | −0.51 | −1.48 | 0.46 | 0.298 | 0.00417 | No |
| PSC 3a | −0.48 | −1.28 | 0.33 | 0.243 | 0.00385 | No |
| CA3 | −0.46 | −0.85 | −0.07 | 0.02 | 0.00217 | No |
| EC | −0.34 | −1.33 | 0.64 | 0.486 | 0.00556 | No |
| HATA | −0.29 | −0.9 | 0.33 | 0.355 | 0.005 | No |
| SF | −0.13 | −1.27 | 1.01 | 0.82 | 0.01 | No |
| PSC 3b | −0.02 | −0.75 | 0.7 | 0.947 | 0.01667 | No |
| PSC 2 | 0.01 | −0.81 | 0.83 | 0.987 | 0.05 | No |
| CM | 0.01 | −0.5 | 0.52 | 0.962 | 0.025 | No |
| PSC 1 | 0.03 | −0.67 | 0.73 | 0.93 | 0.0125 | No |
| Motor 4P | 0.2 | −0.57 | 0.97 | 0.607 | 0.00625 | No |
| Ch4 | 0.27 | −1.06 | 1.6 | 0.688 | 0.00833 | No |
| ASTR | 0.33 | −1.22 | 1.88 | 0.673 | 0.00714 | No |
| Motor 4A | 0.67 | −0.1 | 1.44 | 0.087 | 0.00313 | No |
| Ch123 | 1.24 | −0.35 | 2.83 | 0.125 | 0.00357 | No |